Selected Grants
Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Targeting the B Cell Response to Treat Antibody-Mediated Rejection
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2028The Risks and Opportunities of Homeostatic Repopulation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2028Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients
ResearchCollaborator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028Stimulating Access to Research in Residency (StARR) - NIAID
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 2018 - 2029Advanced Immunobiology Traning Program for Surgeons
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2019 - 2029Targeting the B Cell Response to Treat Antibody-Mediated Rejection
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2021 - 2028The Risks and Opportunities of Homeostatic Repopulation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2022 - 2028Overcoming humoral rejection after xenotransplantation in sensitized nonhuman primate recipients
ResearchCollaborator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2028Overcoming humoral rejection following xenotransplantation via targeting complement C3
ResearchCo Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2023 - 2025VEL-101 NHP Study
ResearchPrincipal Investigator · Awarded by Veloxis Pharmaceuticals · 2023 - 2025EVALUATION OF PATIENT OUTCOMES FROM THE KIDNEY ALLOGRAFT OUTCOMES ALLOSURE REGISTRY (KOAR) AGREEMENT
ResearchPrincipal Investigator · Awarded by CareDx, Inc. · 2018 - 2025Mathematical modeling for optimal control of BK virus infection in kidney transplant recipients
ResearchCo Investigator · Awarded by National Institute of Allergy and Infectious Diseases · 2023 - 2025Miromatrix SRA
ResearchPrincipal Investigator · Awarded by Miromatrix Medical Inc. · 2024 - 2025Novel development ofan acoustofluidic device for targeted antibody removal in pediatric organ transplan rejection
ResearchCollaborator · Awarded by National Institutes of Health · 2021 - 2025ITN089ST (ADAPT) - Measuring Allospecific Impact Of Belatacept/Carfilzomib Desensitization
Clinical TrialPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2021 - 2025ITN336 Immune Tolerance Network
ResearchPrincipal Investigator · Awarded by Benaroya Research Institute at Virginia Mason · 2019 - 2025Transplant Infectious Diseases Interdisciplinary Research Training Grant (TIDIRTG)
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024Duke CTSA (TL1) Year 5
Inst. Training Prgm or CMEMentor · Awarded by National Institutes of Health · 2018 - 2024The Effect of a Desensitization Protocol in Highly Sensitized Renal Transplant Recipients on T Follicular Helper Cells
FellowshipPrincipal Investigator · Awarded by National Institutes of Health · 2023 - 2024Investigation of complement blockade in murine heart transplant model
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2023 - 2024Promoting humoral tolerance via targeting complement C3
ResearchCo Investigator · Awarded by The Board of Regents of the University of Wisconsin System · 2022 - 2024AlloVir P105-401 Registry
Clinical TrialPrincipal Investigator · Awarded by Allovir, Inc. · 2022 - 2024IMAGINE
Clinical TrialPrincipal Investigator · Awarded by CSL Behring LLC · 2020 - 2024Allo Vir ALVR105
Clinical TrialPrincipal Investigator · Awarded by Allovir, Inc. · 2021 - 2023Antibody and B cell kinetics following IdeS (Imlipidase) administration in a sensitized non-human primate model
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2022 - 2023Targeting complement C3 to prevent acute antibody-mediated rejection for a deceased-donor kidney transplant in sensitized recipients
ResearchPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2021 - 2023Developing clinically relevant immunosuppressive regimen for pig to rhesus kidney transplantation using transgenic pigs
ResearchPrincipal Investigator · Awarded by eGenesis, Inc. · 2021 - 2023Acoustic Device to Prevent Antibody Mediated Organ Transplant Failure
ResearchCollaborator · Awarded by Hartwell Foundation · 2019 - 2023LET vs VGCV for Prevention of CMV disease in Kidney Transplant Recipients
Clinical TrialPrincipal Investigator · Awarded by Merck Sharp & Dohme · 2017 - 2023Alexion Sponsored Research Agreement
ResearchPrincipal Investigator · Awarded by Alexion Pharmaceuticals, Inc. · 2020 - 2022The Risks and Opporunities of Homeostatic Repopulation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2017 - 2022Targeting mitochondrial dysfunction and damage-associated molecular patterns to improve the function of high risk grafts in liver transplantation
ResearchMentor · Awarded by National Institutes of Health · 2020 - 2022Measuring the Impact of Allosensitization on Xenotransplantation
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2020 - 2022IM101-823 - Abatacept for treatment of recurrent or de novo autoimmune hepatitis
Clinical TrialPrincipal Investigator · Awarded by The Bristol-Myers/Sanofi Pharmaceuticals, Inc. Partnership · 2019 - 2021Acoustic based plasmapheresis to prevent antibody-mediated organ transplant
ResearchCo Investigator · Awarded by The Board of Regents of the University of Wisconsin System · 2019 - 2021Lung Transplant Plasmapheresis (PLEX)/Belatacept/Carfilzomib Protocol for Treatment of Antibody Mediated Rejection (AMR) and Desensitization
Clinical TrialPrincipal Investigator · Awarded by Bristol-Myers Squibb Company · 2019 - 2020ASTS Presidential Student Mentor Grant
FellowshipPrincipal Investigator · Awarded by American Society of Transplant Surgeons · 2019 - 2019Transplant Tolerance in Non-Human Primates
ResearchPrincipal Investigator · Awarded by Emory University · 2015 - 2017Preventing allograft rejection but not tolerance by blockade of the lymphocyte store-operated calcium channel
ResearchPrincipal Investigator · Awarded by Department of Defense · 2016 - 2017Visiting Research Fellowship
FellowshipPrincipal Investigator · Awarded by King's College London · 2015 - 2016Prevention of Homograft Induced Cardiac Allograft Vasculopathy in Pediatric Heart Transplantation
ResearchCollaborator · Awarded by Enduring Hearts · 2015 - 2016Preventing allograft rejection but not tolerance by blockade of the lymphocyte store-operated calcium channel
ResearchPrincipal Investigator · Awarded by Synta Pharmaceuticals Corp. · 2015 - 2016Inducible Regulatory B Cells in Transplantation Tolerance
ResearchPrincipal Investigator · Awarded by University of Wisconsin · 2015 - 2016External Relationships
- Mallinckrodt Pharmaceuticals
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
- Allovir
- Hanall BioPharma
- Hansa BioPharma
- Mallinckrodt Pharmaceuticals
- Alexion Pharmaceuticals, Inc. a subsidiary of AstraZeneca
- Allovir
- Hanall BioPharma
- Hansa BioPharma
- Pfizer Inc.
- Renovar
- Summome
- Visterra
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.